SIFT drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (16)
Papers in which this entity is mentioned.
- dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. (2020)
- Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
- GAVIN: Gene-Aware Variant INterpretation for medical sequencing. (2017)
- Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines. (2017)
- New insights into the generation and role of de novo mutations in health and disease. (2016)
- Assessing the Pathogenicity of Insertion and Deletion Variants with the Variant Effect Scoring Tool (VEST-Indel). (2016)
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. (2016)
- The human gene damage index as a gene-level approach to prioritizing exome variants. (2015)
- MBASED: allele-specific expression detection in cancer tissues and cell lines. (2014)
- Candidate gene association studies: a comprehensive guide to useful in silico tools. (2013)
- The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation. (2013)
- Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. (2013)
- Evolution and functional impact of rare coding variation from deep sequencing of human exomes. (2012)
- Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. (2009)
- SNPs3D: candidate gene and SNP selection for association studies. (2006)
- SIFT: Predicting amino acid changes that affect protein function. (2003)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| sift | drug | 16 | 26 |